These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2892406)

  • 1. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
    Ostro MJ
    Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for selection of parenteral histamine (H2)-receptor antagonists.
    Wolfe MM
    Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulceration in the intensive care unit: use of H2-receptor antagonists.
    Moore JG
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():111-9. PubMed ID: 1679669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-related mucosal damage: review of drug therapy.
    Vorder Bruegge WF; Peura DA
    J Clin Gastroenterol; 1990; 12 Suppl 2():S35-40. PubMed ID: 1978844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patients.
    Schentag JJ; Carter CA; Welage LS
    DICP; 1989 Oct; 23(10 Suppl):S36-9. PubMed ID: 2573208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K; Yabe S
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for the use of parenteral H2-receptor antagonists.
    Thompson JC; Walker JP
    Am J Med; 1984 Nov; 77(5B):111-5. PubMed ID: 6150638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppression in critically ill patients: what does the evidence support?
    Spirt MJ
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of acid in upper gastrointestinal haemorrhage due to ulcer and stress-related mucosal damage.
    Peterson WL
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():43-6. PubMed ID: 7495942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-related mucosal damage.
    Peura DA
    Clin Ther; 1986; 8 Suppl A():14-23. PubMed ID: 2878727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving perspectives on parenteral H2-receptor antagonist therapy.
    Peura DA; Freston JW
    Am J Med; 1987 Dec; 83(6A):1-2. PubMed ID: 2892403
    [No Abstract]   [Full Text] [Related]  

  • 16. Stress-related mucosal damage: an overview.
    Peura DA
    Am J Med; 1987 Dec; 83(6A):3-7. PubMed ID: 3321976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical review of continuous infusion H2 receptor therapy.
    Rovers JP; Souney PF
    Crit Care Med; 1989 Aug; 17(8):814-21. PubMed ID: 2568898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.